Kuwait
Kuwait approves new treatment for mild COVID-19 cases
Kuwait’s Ministry of Health has approved GSK and Vir Biotechnology’s Sotrovimab as a treatment for coronavirus, state news KUNA reported on Wednesday.
Kuwait is the second country in the Middle East to approve the use of the antibody treatment for mild to moderate Covid-19 cases, after the UAE.